Annual CFI
$18.21 M
-$5.13 M-21.97%
December 31, 2024
Summary
- As of February 25, 2025, ITRM annual cash flow from investing activities is $18.21 million, with the most recent change of -$5.13 million (-21.97%) on December 31, 2024.
- During the last 3 years, ITRM annual CFI has risen by +$72.80 million (+133.35%).
- ITRM annual CFI is now -54.59% below its all-time high of $40.10 million, reached on December 31, 2019.
Performance
ITRM Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$1.10 M
-$4.60 M-80.70%
December 1, 2024
Summary
- As of February 25, 2025, ITRM quarterly cash flow from investing activities is $1.10 million, with the most recent change of -$4.60 million (-80.70%) on December 1, 2024.
- Over the past year, ITRM quarterly CFI has dropped by -$4.60 million (-80.70%).
- ITRM quarterly CFI is now -96.87% below its all-time high of $35.09 million, reached on March 31, 2019.
Performance
ITRM Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$18.21 M
-$12.42 M-40.56%
December 1, 2024
Summary
- As of February 25, 2025, ITRM TTM cash flow from investing activities is $18.21 million, with the most recent change of -$12.42 million (-40.56%) on December 1, 2024.
- Over the past year, ITRM TTM CFI has dropped by -$12.42 million (-40.56%).
- ITRM TTM CFI is now -73.55% below its all-time high of $68.85 million, reached on September 30, 2019.
Performance
ITRM TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
ITRM Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -22.0% | -80.7% | -40.6% |
| 3 y3 years | +133.3% | -80.7% | -40.6% |
| 5 y5 years | -54.6% | -80.7% | -40.6% |
ITRM Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -22.0% | +133.3% | -93.1% | +106.9% | -40.6% | +133.3% |
| 5 y | 5-year | -54.6% | +133.3% | -93.1% | +103.2% | -54.6% | +133.1% |
| alltime | all time | -54.6% | +133.3% | -96.9% | +103.2% | -73.5% | +133.1% |
Iterum Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $18.21 M(-22.0%) | - | - |
| Dec 2024 | - | $1.10 M(-80.7%) | $18.21 M(-40.6%) |
| Sep 2024 | - | $5.70 M(+35.8%) | $30.63 M(+21.1%) |
| Jun 2024 | - | $4.20 M(-41.8%) | $25.29 M(-0.6%) |
| Mar 2024 | - | $7.21 M(-46.7%) | $25.44 M(+9.0%) |
| Dec 2023 | $23.34 M(+67.2%) | $13.52 M(+3656.4%) | $23.34 M(+64.4%) |
| Sep 2023 | - | $360.00 K(-91.7%) | $14.19 M(-52.2%) |
| Jun 2023 | - | $4.35 M(-14.9%) | $29.68 M(+213.4%) |
| Mar 2023 | - | $5.11 M(+16.6%) | $9.47 M(-32.1%) |
| Dec 2022 | $13.96 M(-125.6%) | $4.38 M(-72.4%) | $13.96 M(+173.0%) |
| Sep 2022 | - | $15.85 M(-199.9%) | $5.11 M(-188.2%) |
| Jun 2022 | - | -$15.86 M(-265.3%) | -$5.80 M(-47.7%) |
| Mar 2022 | - | $9.59 M(-314.8%) | -$11.08 M(-79.7%) |
| Dec 2021 | -$54.59 M(>+9900.0%) | -$4.47 M(-190.5%) | -$54.59 M(+8.9%) |
| Sep 2021 | - | $4.93 M(-123.3%) | -$50.13 M(-9.0%) |
| Jun 2021 | - | -$21.14 M(-37.7%) | -$55.07 M(+62.3%) |
| Mar 2021 | - | -$33.92 M(<-9900.0%) | -$33.93 M(>+9900.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$11.00 K(-100.0%) | $0.00(-100.0%) | -$11.00 K(-15.4%) |
| Sep 2020 | - | -$9000.00(+350.0%) | -$13.00 K(-161.9%) |
| Jun 2020 | - | -$2000.00(<-9900.0%) | $21.00 K(-99.6%) |
| Mar 2020 | - | $0.00(-100.0%) | $5.01 M(-87.5%) |
| Dec 2019 | $40.10 M(-563.2%) | -$2000.00(-108.0%) | $40.10 M(-41.8%) |
| Sep 2019 | - | $25.00 K(-99.5%) | $68.85 M(+34.9%) |
| Jun 2019 | - | $4.99 M(-85.8%) | $51.05 M(+199.0%) |
| Mar 2019 | - | $35.09 M(+22.1%) | $17.07 M(-297.2%) |
| Dec 2018 | -$8.66 M(-72.6%) | $28.75 M(-261.7%) | -$8.66 M(-72.0%) |
| Sep 2018 | - | -$17.77 M(-38.7%) | -$30.96 M(+84.1%) |
| Jun 2018 | - | -$28.99 M(-409.8%) | -$16.82 M(-22.5%) |
| Mar 2018 | - | $9.36 M(+45.2%) | -$21.71 M(-31.3%) |
| Dec 2017 | -$31.59 M(<-9900.0%) | $6.45 M(-277.3%) | -$31.59 M(-16.9%) |
| Sep 2017 | - | -$3.64 M(-89.3%) | -$38.03 M(+10.6%) |
| Jun 2017 | - | -$33.88 M(+6440.3%) | -$34.40 M(+6540.3%) |
| Mar 2017 | - | -$518.00 K | -$518.00 K |
| Dec 2016 | $0.00 | - | - |
FAQ
- What is Iterum Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Iterum Therapeutics?
- What is Iterum Therapeutics annual CFI year-on-year change?
- What is Iterum Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Iterum Therapeutics?
- What is Iterum Therapeutics quarterly CFI year-on-year change?
- What is Iterum Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Iterum Therapeutics?
- What is Iterum Therapeutics TTM CFI year-on-year change?
What is Iterum Therapeutics annual cash flow from investing activities?
The current annual CFI of ITRM is $18.21 M
What is the all time high annual CFI for Iterum Therapeutics?
Iterum Therapeutics all-time high annual cash flow from investing activities is $40.10 M
What is Iterum Therapeutics annual CFI year-on-year change?
Over the past year, ITRM annual cash flow from investing activities has changed by -$5.13 M (-21.97%)
What is Iterum Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of ITRM is $1.10 M
What is the all time high quarterly CFI for Iterum Therapeutics?
Iterum Therapeutics all-time high quarterly cash flow from investing activities is $35.09 M
What is Iterum Therapeutics quarterly CFI year-on-year change?
Over the past year, ITRM quarterly cash flow from investing activities has changed by -$4.60 M (-80.70%)
What is Iterum Therapeutics TTM cash flow from investing activities?
The current TTM CFI of ITRM is $18.21 M
What is the all time high TTM CFI for Iterum Therapeutics?
Iterum Therapeutics all-time high TTM cash flow from investing activities is $68.85 M
What is Iterum Therapeutics TTM CFI year-on-year change?
Over the past year, ITRM TTM cash flow from investing activities has changed by -$12.42 M (-40.56%)